Vascular Inflammation Is Associated with Loss of Aquaporin 1 Expression on Endothelial Cells and Increased Fluid Leakage in SARS-CoV-2 Infected Golden Syrian Hamsters.
COVID-19
SARS-CoV-2
aquaporin 1
endothelium
hamster
perivascular edema
vasculitis
vasculopathy
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
08 04 2021
08 04 2021
Historique:
received:
11
03
2021
revised:
01
04
2021
accepted:
06
04
2021
entrez:
30
4
2021
pubmed:
1
5
2021
medline:
4
6
2021
Statut:
epublish
Résumé
Vascular changes represent a characteristic feature of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection leading to a breakdown of the vascular barrier and subsequent edema formation. The aim of this study was to provide a detailed characterization of the vascular alterations during SARS-CoV-2 infection and to evaluate the impaired vascular integrity. Groups of ten golden Syrian hamsters were infected intranasally with SARS-CoV-2 or phosphate-buffered saline (mock infection). Necropsies were performed at 1, 3, 6, and 14 days post-infection (dpi). Lung samples were investigated using hematoxylin and eosin, alcian blue, immunohistochemistry targeting aquaporin 1, CD3, CD204, CD31, laminin, myeloperoxidase, SARS-CoV-2 nucleoprotein, and transmission electron microscopy. SARS-CoV-2 infected animals showed endothelial hypertrophy, endothelialitis, and vasculitis. Inflammation mainly consisted of macrophages and lower numbers of T-lymphocytes and neutrophils/heterophils infiltrating the vascular walls as well as the perivascular region at 3 and 6 dpi. Affected vessels showed edema formation in association with loss of aquaporin 1 on endothelial cells. In addition, an ultrastructural investigation revealed disruption of the endothelium. Summarized, the presented findings indicate that loss of aquaporin 1 entails the loss of intercellular junctions resulting in paracellular leakage of edema as a key pathogenic mechanism in SARS-CoV-2 triggered pulmonary lesions.
Identifiants
pubmed: 33918079
pii: v13040639
doi: 10.3390/v13040639
pmc: PMC8069375
pii:
doi:
Substances chimiques
Aquaporin 1
146410-94-8
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Federal Ministry of Education and Research (BMBF)
ID : 01KI1723G
Organisme : Ministry of Science and Culture of Lower Saxony
ID : 14 - 76103-184 CORONA-15/20
Organisme : German Research Foundation (Deutsche Forschungsgemeinschaft)
ID : 406109949
Organisme : federal ministry of health (BMG)
ID : Covid-19 Rapid Response Grant
Références
Acta Neuropathol. 2020 Jul;140(1):1-6
pubmed: 32449057
JAMA. 2020 Feb 25;323(8):709-710
pubmed: 31999307
Physiol Rev. 2005 Jan;85(1):1-31
pubmed: 15618476
Intervirology. 1987;27(4):218-23
pubmed: 2826361
Nat Rev Immunol. 2007 Oct;7(10):803-15
pubmed: 17893694
J Clin Invest. 1999 Apr;103(7):1007-13
pubmed: 10194473
Nat Rev Immunol. 2020 Jul;20(7):389-391
pubmed: 32439870
Front Pharmacol. 2020 Aug 14;11:1278
pubmed: 32922297
Cell Adh Migr. 2010 Apr-Jun;4(2):204-6
pubmed: 20168076
Am J Respir Cell Mol Biol. 2000 Jan;22(1):34-44
pubmed: 10615063
Folia Neuropathol. 2014;52(1):10-21
pubmed: 24729339
Exp Cell Res. 2019 Sep 15;382(2):111486
pubmed: 31255598
J Innate Immun. 2018;10(1):3-13
pubmed: 28988241
JCI Insight. 2020 Jun 18;5(12):
pubmed: 32379723
Pflugers Arch. 2019 Apr;471(4):519-532
pubmed: 30397774
Am J Respir Crit Care Med. 2021 Jan 15;203(2):192-201
pubmed: 33217246
Lancet. 2020 May 2;395(10234):1417-1418
pubmed: 32325026
Acta Physiol Scand Suppl. 1979;463:11-32
pubmed: 382743
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
N Engl J Med. 2020 Jul 9;383(2):120-128
pubmed: 32437596
N Engl J Med. 2020 Aug 27;383(9):886-887
pubmed: 32678531
J Thromb Thrombolysis. 2020 Oct;50(3):499-511
pubmed: 32700024
Front Physiol. 2018 Feb 16;9:101
pubmed: 29503618
Int J Biol Sci. 2021 Jan 1;17(1):62-72
pubmed: 33390833
J Exp Med. 2020 Dec 7;217(12):
pubmed: 32926098
J Leukoc Biol. 1995 Feb;57(2):343-51
pubmed: 7852849
J Gen Physiol. 2001 Jun;117(6):573-82
pubmed: 11382807
Vet Immunol Immunopathol. 2017 Feb;184:42-53
pubmed: 28166931
Nature. 2020 Jul;583(7818):834-838
pubmed: 32408338
Histopathology. 2018 Feb;72(3):516-524
pubmed: 28858401
J Clin Med. 2020 Jun 28;9(7):
pubmed: 32605192
Science. 2020 Jun 5;368(6495):1039-1040
pubmed: 32499417
Crit Rev Immunol. 2012;32(6):463-88
pubmed: 23428224
Proc Natl Acad Sci U S A. 2020 Jul 14;117(28):16587-16595
pubmed: 32571934
Arterioscler Thromb Vasc Biol. 2011 May;31(5):969-79
pubmed: 21508343
Am J Respir Cell Mol Biol. 2020 Dec;63(6):856-859
pubmed: 32897757
J Trauma Acute Care Surg. 2012 Nov;73(5):1106-13
pubmed: 22976418
Autoimmunity. 2015 May;48(3):139-51
pubmed: 25811915
Respir Med. 2020 Nov - Dec;174:106193
pubmed: 33096317
Trends Mol Med. 2021 Apr;27(4):314-331
pubmed: 33309601
J Immunol. 1997 Nov 1;159(9):4532-8
pubmed: 9379054
Proc Natl Acad Sci U S A. 1993 Aug 1;90(15):7275-9
pubmed: 8346245
Br J Pharmacol. 2020 Nov;177(21):4851-4865
pubmed: 32462701
Lancet Rheumatol. 2021 Mar;3(3):e224-e233
pubmed: 33521655
Brain Behav Immun. 2020 Oct;89:579-586
pubmed: 32629042
Arch Med Sci. 2013 Oct 31;9(5):916-21
pubmed: 24273579
Cureus. 2020 Nov 28;12(11):e11750
pubmed: 33403180
Future Virol. 2020 Oct;:
pubmed: 33576582
Autoimmun Rev. 2017 Aug;16(8):833-844
pubmed: 28564617
J Trauma Acute Care Surg. 2012 Jan;72(1):150-61
pubmed: 22310126
Acta Neuropathol. 1996 Sep;92(3):273-80
pubmed: 8870829
Diagnostics (Basel). 2020 Aug 09;10(8):
pubmed: 32784826
N Engl J Med. 2003 Jul 10;349(2):160-9
pubmed: 12853590
Front Immunol. 2021 Apr 12;12:640842
pubmed: 33912167
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Am J Hematol. 2020 Dec;95(12):1578-1589
pubmed: 32857878
Lancet. 2003 May 24;361(9371):1773-8
pubmed: 12781536
Viruses. 2020 Jul 20;12(7):
pubmed: 32698441
Front Pharmacol. 2021 Jan 14;11:579330
pubmed: 33568991